Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

Share Price is delayed by 15 minutes
Get Live Data
35.70    1.90 (5.62%)
Bid:
35.40
Ask:
36.00
Spread: 0.60 (1.695%)
Market Cap: £26.21m
CAR Live PriceLast checked at - London Stock Exchange

Intraday Carclo Share Chart

Trading Update

14 Oct 2016 07:00

RNS Number : 5138M
Carclo plc
14 October 2016
 

14 October 2016

Carclo plc

("Carclo", the "Company" or the "Group")

 

Trading Update

 

The Board is pleased to announce that the Group has continued to trade well in the current financial year and its trading performance remains in line with the Board's expectations for the year ending 31 March 2017. The Group will announce its results for the half year ended 30 September 2016 on 15 November 2016.

 

Technical Plastics delivered a good first half performance with customer demand in line with the Board's expectations and growing net margins; the Board expects this division to have a stronger second half trading performance. In LED Technologies, our Wipac luxury and supercar lighting business has performed well, demonstrating good product demand and with all of its current design, development and tooling projects on plan; this division is expected to report another strong performance in the second half of the financial year. The Aerospace division has benefited from stable demand in the first half of the financial year and is expected to trade in line with the Board's expectations for the full year.

 

Approximately two thirds of Group revenue is currently derived from outside the UK and, therefore, movements in foreign exchange rates have an impact on our financial results. The Group had foreign exchange contracts in place prior to the EU Referendum and this has limited the net benefit from foreign exchange rates in the first half of the financial year. Assuming that sterling does not strengthen significantly, we do expect some further net benefit from the retranslation of overseas profits during the second half of the financial year.

 

Group debt was slightly higher as at 30 September 2016 than at 31 March 2016 primarily due to the impact of currency movements on the re-translation of the Group's US dollar and Euro denominated medium term loans. Group debt is expected to reduce by 31 March 2017.

 

As outlined in our trading statement of 31 August 2016, the Group's IAS 19 pension deficit is expected to have increased significantly due to the material decrease in the corporate bond yield used to discount the pension liability. However, the cash cost of the pension deficit has remained at similar levels with the Group paying in the current year an annual recovery plan payment of £1.2 million and pension scheme administration costs of £0.7 million. As expected, due to the materially increased IAS19 pension deficit extinguishing the Company's distributable reserves, the Group did not pay the recommended final dividend of 1.95 pence per share which was referred to in the results announcement made on 7 June 2016.

 

The Board continues to look forward to a year of strong trading and good growth in both of its main divisions.

 

Enquiries:

Carclo plc

01924 268040

Chris Malley, Chief Executive

Robert Brooksbank, Finance Director

Weber Shandwick Financial

020 7067 0700

Nick Oborne

 

 

 

Notes to editors

 

Carclo plc is a public company whose shares are quoted on the London Stock Exchange.

 

Carclo's strategy is to develop and expand its key manufacturing assets where there remain significant further opportunities to drive value. To enhance profit margins and support customers the Group has been investing in lower cost regions and new technologies.

 

Approximately three fifths of Group revenues are derived from the supply of fine tolerance, injection moulded plastic components, mainly for medical products. The balance of revenue is derived mainly from the design and supply of specialised injection moulded LED based lighting systems to the low volume premium automotive industry.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFIIIDLVLIR
Date   Source Headline
3rd May 20194:39 pmRNSHolding(s) in Company
23rd Apr 201911:20 amRNSHolding(s) in Company
18th Apr 20199:32 amRNSHolding(s) in Company
17th Apr 20197:00 amRNSYear-End Trading Update
26th Mar 201912:07 pmRNSSecond Price Monitoring Extn
26th Mar 201912:02 pmRNSPrice Monitoring Extension
26th Feb 20197:00 amRNSHolding(s) in Company
22nd Feb 201910:52 amRNSHolding(s) in Company
19th Feb 20199:39 amRNSAppointment of Chief Operating Officer
19th Feb 20199:16 amRNSHolding(s) in Company
7th Feb 20193:32 pmRNSHolding(s) in Company
6th Feb 20195:57 pmRNSHolding(s) in Company
6th Feb 20191:57 pmRNSHolding(s) in Company
6th Feb 20191:56 pmRNSHolding(s) in Company
6th Feb 201911:51 amRNSHolding(s) in Company
6th Feb 201911:51 amRNSDirector/PDMR Shareholding
31st Jan 201911:12 amRNSHolding(s) in Company
16th Jan 201912:37 pmRNSHolding(s) in Company
16th Jan 201911:43 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSTrading Statement
21st Nov 20182:49 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSHalf-year Report
12th Oct 20187:00 amRNSTrading Update
29th Aug 20185:08 pmRNSHolding(s) in Company
13th Aug 201811:39 amRNSDirector/PDMR Shareholding
9th Aug 20188:08 amRNSForm 8.3 - [Carclo plc]
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
8th Aug 20188:46 amRNSForm 8.3 - [Carclo plc]
7th Aug 20181:46 pmRNSHolding(s) in Company
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 201810:36 amRNSForm 8.3 - [Carclo plc]
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
1st Aug 20182:52 pmRNSDirector/PDMR Shareholding
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
1st Aug 20189:47 amRNSForm 8 (DD) - Carclo
1st Aug 20189:41 amRNSForm 8 (DD) - Carclo
1st Aug 20189:38 amRNSPerformance Share Plan
1st Aug 20188:19 amRNSForm 8.3 - [Carclo plc]
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
31st Jul 201811:01 amRNSForm 8 (DD) - Carclo
31st Jul 201810:54 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.